Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_assertion type Assertion NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_head.
- NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_provenance.
- NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_assertion evidence source_evidence_literature NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_provenance.
- NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_assertion SIO_000772 22662110 NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_provenance.
- NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_assertion wasDerivedFrom befree-20150227 NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_provenance.
- NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_assertion wasGeneratedBy ECO_0000203 NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_provenance.